From an interventional study to a national scale-up: lessons learned from the Malakit strategy at the French Guiana–Suriname border

Malaria Journal

Case Study

Stephen Vreden¹  Yann Lambert²  Irene Jimeno²  Muriel Suzanne Galindo²  Alice Sanna²  Maylis Douine³  Antoine Adenis³  Martha Suarez-Mutis⁴  Hélène Hiwat⁵  Hedley Cairo⁵ 

[1] Foundation for the Advancement of Scientific Research, Paramaribo, Suriname;Inserm CIC 1424, Cayenne Hospital, Centre d’Investigation Clinique Antilles-Guyane, Cayenne, French Guiana;Inserm CIC 1424, Cayenne Hospital, Centre d’Investigation Clinique Antilles-Guyane, Cayenne, French Guiana;TBIP, CNRS, Inserm, U1019-UMR9017-CIIL Centre d’Infection et d’Immunité de Lille, Institut Pasteur de Lille, Université de Guyane, Université de Lille, Cayenne, French Guiana;Laboratory of Parasitic Diseases, Institute Oswaldo Cruz/Fiocruz, Rio de Janeiro, Brazil;National Malaria Elimination Programme, Ministry of Health of Suriname, Paramaribo, Suriname;

关键词: Scale-up;    Malaria;    Intervention;    Elimination;    Guiana Shield;    Gold miners;    Innovation;    Amazon;   

DOI  :  10.1186/s12936-023-04672-6

 received in 2023-07-01, accepted in 2023-08-11,  发布年份 2023

来源: Springer

【 摘 要 】

Scaling-up an experimental intervention is always a challenge. On the border between French Guiana, Brazil and Suriname, an interventional study demonstrated the effectiveness of distributing self-diagnosis and self-treatment kits (Malakits) to control malaria in mobile and hard-to-reach populations. Its integration into the Suriname’s National Malaria Elimination Plan after a 2-year experiment faced numerous challenges, including human resources to cope with the additional workload of coordinators and to maintain the motivation of community health workers. The economic recession in Suriname, the Covid pandemic, and logistical issues also hampered the scale-up. Finally, thanks to the commitment of stakeholders in Suriname and French Guiana, the integration of Malakit distribution into the Surinamese national programme was proved possible.

【 授权许可】

CC BY   
© BioMed Central Ltd., part of Springer Nature 2023

【 图 表 】

42490_2023_74_Article_IEq40.gif